NCT02929056View on ClinicalTrials.gov

Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations

PHASE4TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

September 6, 2018

Study Completion Date

October 29, 2019

Conditions
Varicose UlcerVenous Insufficiency
Interventions
BIOLOGICAL

AmnioExCel dressing and compression therapy

Use of a dehydrated human amnion membrane as a biologic adjunct to the standard of care in patients with venous leg ulcers

PROCEDURE

SOC alginate dressing and compression therapy

Alginate dressing is an absorbent wound care product that contains sodium and calcium fibers to absorb fluids and promote healing

Trial Locations (1)

29615

Greenville Health System, Greenville

Sponsors

Collaborators (1)

BioDlogics
All Listed Sponsors
collaborator

Clemson University

OTHER

collaborator

BioDlogics

INDUSTRY

lead

Prisma Health-Upstate

OTHER

NCT02929056 - Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations | Biotech Hunter | Biotech Hunter